Glossodynia After Osteoporosis Treatment

Am J Med Sci. 2017 May;353(5):502-503. doi: 10.1016/j.amjms.2016.08.012. Epub 2016 Aug 21.

Authors

Ioannis Ilias¹, Evangelia Venaki², Stamatina Nikopoulou², Christian A Koch³

Affiliations

¹ Department of Endocrinology, E Venizelou Hospital, Athens, Greece. Electronic address: iiliasmd@yahoo.com.
² Department of Endocrinology, E Venizelou Hospital, Athens, Greece.
³ Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.

PMID: 28502340
DOI: 10.1016/j.amjms.2016.08.012

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Denosumab / adverse effects*
Female
Glossalgia / chemically induced*
Hashimoto Disease / drug therapy
Humans
Osteoporosis / complications*
Osteoporosis / drug therapy*
Thyroxine / therapeutic use

Substances

Denosumab
Thyroxine